Data, Drugs, and Disruption: Biotech for a Better Future with Ed Fleischer episode artwork

EPISODE · Jul 15, 2025 · 50 MIN

Data, Drugs, and Disruption: Biotech for a Better Future with Ed Fleischer

from The Healthy Enterprise · host Heath Fletcher

In this conversation, Ed Fleischer shares his extensive career journey in the biotech industry, detailing his experiences from working in large pharmaceutical companies to transitioning into consultancy. He discusses the importance of staying current with industry trends, the impact of AI on biotech, and innovations in quality control. Edwin reflects on meaningful experiences that shaped his career, the significance of leadership and communication, and the motivation behind delivering life-changing medicines to patients.Chapters:0:00 - Introduction to Ed Fleischer2:09 - From Biotechnology to Consultancy10:00 - The Journey Through Major Pharma13:00 - Staying Current in a Dynamic Field14:43 - The Impact of AI on QC21:06 - The "Why" Behind the Work32:20 - Leadership and Authenticity36:51 - The Value of Public Speaking42:42 - Delivering on Trust46:11 - Conclusion and TakeawaysGuest Information:Guest's Name:  Ed FleischerGuest's Title/Position: Chief Executive Officer Guest's Linkedin: https://www.linkedin.com/in/ed-fleischer-a780482/Company/Affiliation: Beachside Compliance SolutionsGuest's Bio: Ed Fleischer is a seasoned Quality Control executive with a strong track record of leading quality improvement, operational excellence, and compliance initiatives in the biotechnology industry. With deep expertise in biotechnology processes, quality systems, and regulatory requirements across both domestic and international markets, he has successfully collaborated with agencies such as the FDA, EMA, and others. Ed is also the CEO of Beachside Compliance Solutions, a consultancy specializing in analytical and Quality Control challenges, where he offers independent, expert guidance to organizations navigating complex regulatory environments. He is passionate about developing talent and fostering a culture of quality at all levels of an organization.Takeaways:-He transitioned to consultancy after working in various pharmaceutical companies.-Staying current with regulations and industry trends is crucial for success.-AI is becoming increasingly important in the biotech field.-Innovations in quality control are revolutionizing the industry.-Ed's impactful experience with a patient highlighted the importance of their work.-Leadership requires authenticity and the ability to communicate effectively.-Diversity in teams leads to better problem-solving and innovation.-Consultants care about the outcomes of their work and follow up with clients.-The pharmaceutical industry is driven by the need to deliver safe and effective medicines. 

Episode metadata supplied by the publisher feed · Published Jul 15, 2025

Embed this episode

Ready to play

Data, Drugs, and Disruption: Biotech for a Better Future with Ed Fleischer

0:00 50:17

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Healthy Enterprise?

This episode is 50 minutes long.

When was this The Healthy Enterprise episode published?

This episode was published on July 15, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this The Healthy Enterprise episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!